TY - JOUR
T1 - Sertraline-induced ventricular tachycardia
AU - Patel, Nishit H.
AU - Golwala, Harsh
AU - Stavrakis, Stavros
AU - Schechter, Eliot
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Sertraline is a selective serotonin reuptake inhibitor, which is a commonly used drug for major depressive disorder. Most frequently reported adverse effects of sertraline in patients receiving 50-150 mg/d are dry mouth, headache, diarrhea, nausea, vomiting, sweating, and dizziness. We hereby report one of the few cases of sertraline-induced ventricular tachycardia, which has been for the first time objectively assessed by the Naranjo scale. We therefore urge the primary care physicians and the cardiologists to keep sertraline as a possible precipitating factor for evaluation of ventricular tachycardia.
AB - Sertraline is a selective serotonin reuptake inhibitor, which is a commonly used drug for major depressive disorder. Most frequently reported adverse effects of sertraline in patients receiving 50-150 mg/d are dry mouth, headache, diarrhea, nausea, vomiting, sweating, and dizziness. We hereby report one of the few cases of sertraline-induced ventricular tachycardia, which has been for the first time objectively assessed by the Naranjo scale. We therefore urge the primary care physicians and the cardiologists to keep sertraline as a possible precipitating factor for evaluation of ventricular tachycardia.
KW - Naranjo scale
KW - Sertraline
KW - Ventricular tachycardia
UR - http://www.scopus.com/inward/record.url?scp=84895098450&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84895098450&partnerID=8YFLogxK
U2 - 10.1097/MJT.0b013e3182192d6e
DO - 10.1097/MJT.0b013e3182192d6e
M3 - Article
C2 - 21768871
AN - SCOPUS:84895098450
SN - 1075-2765
VL - 20
SP - e720-e722
JO - American Journal of Therapeutics
JF - American Journal of Therapeutics
IS - 6
ER -